Jump to navigation
Join us on 12/4 at noon, when we welcome Stacie Dusetzina, PhD, from Vanderbilt University. This event is co-sponsored by Pitt Public Health, Department of Health Policy and Management.
In a perspective piece in the New England Journal of Medicine, CP3 Director Walid Gellad and HPI Director Everette James describe the controversy surrounding the 340B Drug Pricing Program.Read more.
In a recent article in JAMA, researchers compared prescription opioid use and medication-assisted treatment rates before and after an overdose.
In a recent perspective piece in NEJM, Dr. Gellad discusses the accelerated approval process in the era of expensive drugs. Read more.
In a commentary in JAMA Internal Medicine, Dr. Walid Gellad discusses the opioid epidemic within the Nation's Veteran population.
In a PLoS One paper, CP3 faculty report that peers strongly influence physician adoption of new drugs.